Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin - Wikidata - awgldk - TriplyDB

Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin

Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin

http://www.wikidata.org/entity/Q35791973

about

Angiotensin receptor blockers and risk of prostate cancer among United States veterans Maternal nutrient restriction and the fetal left ventricle: decreased angiotensin receptor expression Observations on angiopoietin 2 in patients with angiosarcoma Embryonic lethality in Dear gene-deficient mice: new player in angiogenesis Losartan Treatment Protects Retinal Ganglion Cells and Alters Scleral Remodeling in Experimental Glaucoma Insulin-like growth factors, angiopoietin-2, and pigment epithelium-derived growth factor in the hypoxic retina Diabetic retinopathy and blockade of the renin-angiotensin system: new data from the DIRECT study programme.Role of inflammatory cytokine-induced cyclooxygenase 2 in the ocular immunopathologic disease herpetic stromal keratitis.Effects of laser photocoagulation on serum angiopoietin-1, angiopoietin-2, angiopoietin-1/angiopoietin-2 ratio, and soluble angiopoietin receptor Tie-2 levels in type 2 diabetic patients with proliferative diabetic retinopathy.Iron overload in diabetic retinopathy: a cause or a consequence of impaired mechanisms?Infection, oxygen, and immaturity: interacting risk factors for retinopathy of prematurity.Angiotensin II-related hypertension and eye diseases.Associations of VEGF/VEGF-receptor and HGF/c-Met promoter polymorphisms with progression/regression of retinopathy of prematurity.Angiotensin-2-mediated Ca2+ signaling in the retinal pigment epithelium: role of angiotensin-receptor-associated-protein and TRPV2 channel.Gene expression changes in a rat model of oxygen-induced retinopathy.Serum prorenin levels and diabetic retinopathy in type 2 diabetes: new method to measure serum level of prorenin using antibody activating direct kinetic assay Characteristics of Severe Retinopathy of Prematurity in Infants with Birth Weight above 1500 Grams at a Referral Center in Turkey Prevention of VEGF-induced growth and tube formation in human retinal endothelial cells by aldose reductase inhibition AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.Regulation of angiotensin II receptors and extracellular matrix turnover in human retinal pigment epithelium: role of angiotensin II Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures.Short hairpin RNA-mediated knockdown of VEGFA in Müller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity.The renin-angiotensin system and malignancy.The significance of neuronal and glial cell changes in the rat retina during oxygen-induced retinopathy.Mediators of ocular angiogenesis.Effect of systemic medications on onset and progression of diabetic retinopathy.The role of glia in retinal vascular disease.Anti-angiogenic Therapy for Retinal Disease.On the use of antiangiogenetic medications for retinopathy of prematurity Expression of classical components of the renin-angiotensin system in the human eye.Therapeutic targets of renin-angiotensin system in ocular disorders.Role of Tissue Renin-angiotensin System and the Chymase/angiotensin-(1-12) axis in the Pathogenesis of Diabetic Retinopathy.Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.The effect of baicalin in a mouse model of retinopathy of prematurity.Role of Ang1 and its interaction with VEGF-A in astrocytomas.Many Faces of Renin-angiotensin System - Focus on Eye.Renin-Angiotensin system hyperactivation can induce inflammation and retinal neural dysfunction.Role of Angiopoietins and Tie-2 in Diabetic Retinopathy.Potential role for angiotensin-converting enzyme inhibitors in the treatment of glaucoma.Differential expression of interleukin 1 receptor type II during mouse decidualization.

P2860

Q24626548-3DD680CC-F97D-4686-9956-255A5396D870 Q24814209-FAE9548B-F956-4AE1-98EC-929EC135AB3E Q28262303-9EA033F8-265B-4816-A3B6-BEF99E2EC92D Q28506779-0BACF748-15C1-4D84-BC89-D77D83E73F15 Q28550525-D86C0072-0755-4084-948B-B90F50AA41DB Q28566886-89EA7C37-383B-4EB9-806E-35EE177BC51E Q33489427-8C626344-6CF3-49F6-B08E-25EA1F9814FC Q33912065-BA5C4BD5-DED1-4DDE-A5A3-5B37150AAEDF Q34063056-7FBF7B97-D7D9-43EB-8B5C-3FB325B9C819 Q34109492-22A3E5F7-2014-4098-93E8-F47CD41A24FA Q34130329-86D04BA7-9B29-4CDF-8BEB-7C11F0EB2193 Q34251889-2B8D4E41-5C4A-4AC4-9A44-CA639636C0B1 Q34456779-2E038EA0-F03A-4C89-A482-4E120C0D401E Q34490286-096DF261-9DDC-4789-AA51-167194D63290 Q34575052-D5F8503B-1249-484F-A178-C50C8485D4D3 Q35593360-C9356223-2C27-4DE0-8ED4-2B975B04416F Q36109238-B7689A68-C426-4CAD-BA00-8E950069F2E7 Q36209915-C18B69A4-5DB6-46F2-A383-79293AC76B42 Q36573232-F98A928F-99C4-41FB-8E61-D64829B3550E Q37016739-D1D0C482-8E11-4B4E-88CE-D1ACC2D13AEB Q37091141-7FB53E43-7A7F-4BFC-879C-F0A36B732D02 Q37149035-A9385EAB-6C7D-4338-8C68-82B35E98A164 Q37218569-4B7EB635-112B-416A-B767-B96287945729 Q37599582-EC4A3FF9-AB5A-47B9-93F2-26F9308D8371 Q37678807-9B34CF36-EA7C-4DFE-AC95-18FA84818D19 Q37776148-BA874FF4-4751-4C76-8548-B3B7804D049B Q38004034-9FE4C054-AEB3-4B12-8788-A3F43028F4AC Q38805247-8B9BF1A6-2C47-4B61-BD52-54E7F9EEC98E Q38906895-C971E88C-30F1-4818-9E9C-C6CE163EE1A2 Q38950146-45A73E8C-B66F-4583-8538-F5780CFCC4C1 Q39214578-AD602655-284B-41E1-BE80-630F2DA39C3E Q39238324-13C8D619-D7DF-4553-BBA9-802A3E602E5B Q39901974-39A5ECFC-A307-440D-A260-5454948549E6 Q40217500-7F05FCDD-E6CC-453A-9CA4-771E0AA2C645 Q40510010-684F59B6-F7D3-4F55-850D-60F36A1B6986 Q41015495-3B72468C-89B1-4992-88BB-AED0E02287E3 Q42098043-F142395A-CBB0-4039-A4CA-F4675BC275ED Q42364223-BBB3A842-9E16-4730-A61D-DED91A7ABF81 Q43106907-BF02DB24-4DBA-4670-9F6F-0F1C2B467EBE Q44848221-1371D2A5-7711-4298-8C96-AFF837525142

P2860

Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin

http://www.wikidata.org/entity/Q35791973

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Retinal angiogenesis is mediat ...... ceptor, VEGF, and angiopoietin

@ast

Retinal angiogenesis is mediat ...... ceptor, VEGF, and angiopoietin

@en

type

label

Retinal angiogenesis is mediat ...... ceptor, VEGF, and angiopoietin

@ast

Retinal angiogenesis is mediat ...... ceptor, VEGF, and angiopoietin

@en

prefLabel

Retinal angiogenesis is mediat ...... ceptor, VEGF, and angiopoietin

@ast

Retinal angiogenesis is mediat ...... ceptor, VEGF, and angiopoietin

@en

P1433

Q35791973-B0D7FEB1-10C9-4217-ADA1-5C41D9E1EC8A

P1476

Q35791973-AACC0E83-1D69-4CCE-B6C0-A373680400E8

P2093

Q35791973-25B26074-D78F-4D40-905E-4EF3C50AFC58

Q35791973-3D9CAB09-853D-45C8-A2D9-81CEF23E6BE8

Q35791973-5D0B9E95-904B-41D1-ADD2-53C226B03E80

Q35791973-CF28B674-9A17-4B85-8432-D5F2EC57E960

Q35791973-D36E18FD-A91A-4093-8174-5C5B5ABD5EB6

P2860

Q35791973-0B2AB7AA-E3DB-4259-A6B9-5561CDAB13C4

Q35791973-0CDC76CD-109F-414E-993F-B7BBFC75EA7A

Q35791973-110B817F-C5E0-4FD9-B50C-68586E15DD06

Q35791973-12CEB1AD-D97D-4E0A-90F7-3158D67528C2

Q35791973-1477A7BD-F27D-46A2-A995-87F4ADD582B9

Q35791973-17C7721A-0439-4A93-8031-4CC0CF9CAFCA

Q35791973-1C0C54DA-1C2A-4ADF-ABF9-C96EFD226607

Q35791973-35484D4D-E50D-4B31-8362-FB7392BF1BE6

Q35791973-397D2B54-BE5B-4CCF-B589-879270DA018D

Q35791973-3A9DD6F7-7EDC-48D2-B613-4AEBFA01311F

P304

Q35791973-3F9BAD5B-83D5-44DE-BE2E-307EADF94116

P31

Q35791973-D1F9DADB-C524-4BC3-ACBD-195B64CB5BA5

P356

Q35791973-A9E79590-86BB-4941-813D-FC85A0976DBA

P407

Q35791973-FB46D236-0C2A-4946-B5A8-C989F45A29AA

P433

Q35791973-B98578FC-B7D5-4710-8429-A58B4DC0B335

P478

Q35791973-D2E46600-D09E-4F27-AEB0-AD801578FB5C

P50

Q35791973-9ACC20B7-04F9-4EEB-885C-98F80A7FD3AF

P577

Q35791973-D2067CA5-7FC8-44A6-BB5C-419FB7D6FBA7

P5875

Q35791973-8B89EE93-D40C-496F-8A9A-6B300ACD1CA0

P698

Q35791973-9B801F3B-CB88-41BD-BCA5-0B50947BDD91

P932

Q35791973-D16DC21A-FB2B-4850-A6A3-D12D9E1DE7F2

P356

S0002-9440(10)63448-7

P1433

The American Journal of Pathology

P1476

Retinal angiogenesis is mediat ...... ceptor, VEGF, and angiopoietin

@en

P2093

Bishoy Rizkalla

http://www.w3.org/2001/XMLSchema#string

Christina J Moravski

http://www.w3.org/2001/XMLSchema#string

Mark E Cooper

http://www.w3.org/2001/XMLSchema#string

Stella Sarlos

http://www.w3.org/2001/XMLSchema#string

Zemin Cao

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth

Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization

Angiotensin AT(1) receptor signalling modulates reparative angiogenesis induced by limb ischaemia

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.

Hyperoxia/normoxia-driven retinal angiogenesis in mice: a role for angiotensin II.

P304

879-887

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)63448-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

163

http://www.w3.org/2001/XMLSchema#string

P50

Jennifer L Wilkinson-Berka

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10599259

http://www.w3.org/2001/XMLSchema#string

P698

12937129

http://www.w3.org/2001/XMLSchema#string

P932

1868261

http://www.w3.org/2001/XMLSchema#string